This week in optometry: November 27-December 1

News
Article

Catch up on what happened in optometry during the week of November 27-December 1.

Catch up with what Optometry Times®' shared this week:

Eye care providers express concern over Q3 revenue, staffing, and inflation

Sydney M Crago, Editor, Modern Retina

The Vision Council has released the results of their Provider InSights research study for Q3 2023. This study explores the sentiments of eye care providers in relation to the daily operations of their practices, the eye care industry, and the American economy and was conducted in October and November of 2023. Those surveyed include opticians, optometrists, ophthalmologists, eye care practice managers, eye care practice owners and other professionals.

Read more...

Managing cases of dry eye: Expect the unexpected

Mile Brujic, OD, FAAO; Lynda Charters

Managing patients with dry eye disease may not be as clear-cut as it appears. Mile Brujic, OD, FAAO, shared his pearls with 2 challenging cases at a recent Ophthalmology Times and Optometry Times Case-Based Roundtable. He is a partner in the Premier Vision Group in Bowling Green, Ohio.

Read more...

FDA issues complete response letter to Aldeyra Therapeutics for reproxalap NDA

David Hutton, Managing Editor, Ophthalmology Times

Aldeyra Therapeutics Inc announced receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) of reproxalap, an investigational drug candidate, for the treatment of dry eye disease.

Read more...

Keep your contact lens practice on the cutting edge

Robert L. Rosenthal, OD

"This case [in this article] illustrates so many things about how to run a successful contact lens practice. First, I don’t ever want my patients to hear about new technology from someone else. I make it a priority that my staff and I stay abreast of the latest innovations so that we can offer better products before patients start complaining—and certainly before they are ready to drop out of lens wear."

Read more...

The relationship between myopia and glaucoma

Benjamin P. Casella, OD, FAAO

One meta-analysis of 145 studies estimates that myopia, which affected 22% of individuals globally in 2000, will be present in 50% of the world’s population by 2050.1 This seems like quite a staggering statistic until you hone in on the developed countries in East Asia, where the prevalence of myopia in school-aged children is 80% to 90%.

Read more...

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.